About: Invitae

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.

Property	Value
dbo:abstract	Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million. (en)
dbo:foundingYear	2010-01-01 (xsd:gYear)
dbo:headquarter	dbr:San_Francisco,_California
dbo:industry	dbr:Genetic_testing
dbo:keyPerson	dbr:Chief_executive_officer
dbo:netIncome	6.089E8
dbo:revenue	2.796E8
dbo:revenueYear	2020-01-01 (xsd:gYear)
dbo:thumbnail	wiki-commons:Special:FilePath/Invitae-logo.png?width=300
dbo:wikiPageExternalLink	https://www.invitae.com/en/ https://www.google.com/finance/quote/NVTA:NYSE https://finance.yahoo.com/quote/nvta https://www.nyse.com/quote/XNYS:NVTA https://www.invitae.com/en
dbo:wikiPageID	1666393 (xsd:integer)
dbo:wikiPageLength	10593 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1099089388 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Caltech dbr:United_States_Department_of_Defense dbr:Pediatric dbr:Corporate_spin-off dbr:Chief_executive_officer dbr:Genetic_testing dbr:Genomic_Health dbr:Miscarriage dbr:Mukilteo,_Washington dbr:Combinatorial_chemistry dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:Research_support_companies dbc:Microarrays dbr:Oncology dbr:Single-nucleotide_polymorphism dbr:San_Francisco,_California dbr:Prenatal_diagnosis dbr:Human_genome_sequence_map dbr:Acacia_Research_Corporation dbr:Postnatal
dbp:hqLocation	San Francisco, California, U.S. (en)
dbp:industry	Genetic testing (en)
dbp:keyPeople	Kenneth D. Knight (en)
dbp:logo	Invitae-logo.png (en)
dbp:name	Invitae Corp. (en)
dbp:netIncome	-US$608.9 million (en)
dbp:netIncomeYear	2020 (xsd:integer)
dbp:revenue	2.796E8
dbp:revenueYear	2020 (xsd:integer)
dbp:tradedAs	NYSE:NVTA (en)
dbp:website	https://www.invitae.com/en
dbp:wikiPageUsesTemplate	dbt:Citation_needed dbt:Infobox_company dbt:Missing_information dbt:Reflist dbt:Short_description dbt:Start_date_and_age
dcterms:subject	dbc:Companies_listed_on_the_New_York_Stock_Exchange dbc:Research_support_companies dbc:Microarrays
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment	Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million. (en)
rdfs:label	Invitae (en)
owl:sameAs	wikidata:Invitae https://global.dbpedia.org/id/4i1bp
prov:wasDerivedFrom	wikipedia-en:Invitae?oldid=1099089388&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Invitae-logo.png
foaf:homepage	https://www.invitae.com/en
foaf:isPrimaryTopicOf	wikipedia-en:Invitae
foaf:name	Invitae Corp. (en)
is dbo:wikiPageRedirects of	dbr:CombiMatrix dbr:Combimatrix dbr:CombiMatrix_Corporation
is dbo:wikiPageWikiLink of	dbr:List_of_bioinformatics_companies dbr:CombiMatrix dbr:Combimatrix dbr:Genomic_Health dbr:Companies_listed_on_the_New_York_Stock_Exchange_(I) dbr:Pharmacogenomics dbr:Acacia_Research dbr:Association_for_Molecular_Pathology dbr:CombiMatrix_Corporation
is foaf:primaryTopic of	wikipedia-en:Invitae